Message From the Vice-President, Research
Discovery to clinical impact via the medical marketplace—that’s the “business” that Sunnybrook Research Institute (SRI) is in, and over the last year we’ve made significant headway.
As with every successful hospital-based research enterprise, our scientists are our most precious assets. We have created an ethos of innovation at SRI, an environment that has some of the best minds in the world who are enabling the most social of activities: discovery.
Our vision of creating an international hub for life sciences is supported by providing space without disciplinary boundaries. Physicists, engineers, geneticists, molecular and cellular biologists, and health services researchers, along with a growing family of business partners, work shoulder-to-shoulder with practitioners and patients toward solving the most challenging problems in medical science.
At first blush, it might seem out of place to have private sector partners walking the hallways of SRI. Their presence, partnership and investment, however, are fundamental to our success. Translating ideas into products that will help our patients is a high-cost, high-risk endeavor.
The result of such partnership is an “end-to-end” solution—from discovery to the uptake of innovative and disruptive technology into the health care system.
Welcome to this year’s SRI Magazine, with its special focus on brain sciences—an area in which we lead. We hope that you enjoy the captivating stories. In-between each line, know that we have implemented a commercialization speedway, one that ensures our patients will benefit from our breakthroughs faster than ever.
Sunnybrook Research Institute
Sunnybrook Health Sciences Centre
Professor, Departments of Immunology and Medical Biophysics
Faculty of Medicine, University of Toronto